<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Progress Notes</a></li><li><a href="#id10">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>AFIB on remote</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Xanax 0.25 MG</td><td ID="instruction1">1 tablet Orally As needed</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Zolpidem Tartrate 10 MG</td><td ID="instruction2">1 tablet at bedtime as needed Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Lyrica 50 MG</td><td ID="instruction3">1 capsule Orally Three times a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">HydrOXYzine HCl 25 MG</td><td ID="instruction4">1 tablet as needed Orally every 8 hrs for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Vitamin D3 10 MCG (400 UNIT)</td><td ID="instruction5">1 tablet Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Sotalol HCl 80 MG</td><td ID="instruction6">1 tablet Orally every 12 hrs</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Rosuvastatin Calcium 20 MG</td><td ID="instruction7">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Calcium 500 MG</td><td ID="instruction8">1 tablet with meals Orally Twice a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Duloxetine HCl 60 MG</td><td ID="instruction9">1 capsule Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Warfarin Sodium 3 MG</td><td ID="instruction10">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Furosemide 40 MG</td><td ID="instruction11">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">Aspirin 81 MG</td><td ID="instruction12">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication13">Entresto 24-26 MG</td><td ID="instruction13">1 tablet Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication14">Carvedilol 12.5 MG</td><td ID="instruction14">1 tablet Orally Twice a day</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Former Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table><span class="content_span">Tobacco Status:</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Patient is</td><td>a former smoker</td><td>non tobacco user</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Height</th><td>70 in</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Weight</th><td>297 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital3">BMI</th><td>42.61 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Blood pressure systolic</th><td>132 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Blood pressure diastolic</th><td>90 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Heart Rate</th><td>75 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital8">Oximetry</th><td>99 </td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>356411HVN HEART INST NO</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Biventricular automatic implantable cardioverter defibrillator in situ Z95.810 ; PAF (paroxysmal atrial fibrillation) I48.0 ; VT (ventricular tachycardia) I47.20 ; Complete AV block I44.2 ; Ischemic cardiomyopathy I25.5 ; H/O mechanical aortic valve replacement Z95.2 ; Mixed hyperlipidemia E78.2 and Severe obesity (BMI &gt;= 40) E66.01</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Biventricular automatic implantable cardioverter defibrillator in situ (ICD-10 - Z95.810)</td><td/><td>[REDACTED] has a longstanding history of paroxysmal atrial fibrillation with low burden of atrial tachyarrhythmia and on suppressive therapy with sotalol with acceptable QTC.  He also has a history of mechanical aortic valve on Coumadin, nonischemic cardiomyopathy with LVEF of 35% per TTE performed in [REDACTED] on guideline directed medical therapy.  As described above he has newly redeveloped atrial fibrillation although he has not had any significant symptoms.  He has reverted to atrially paced rhythm.  I would simply continue current management unless he develops more sustained and symptomatic atrial tachyarrhythmia in which case we could consider catheter ablation.  We will continue to follow his device remotely and see him in follow-up.</td><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>PAF (paroxysmal atrial fibrillation) (ICD-10 - I48.0)</td><td/><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>VT (ventricular tachycardia) (ICD-10 - I47.20)</td><td/><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Complete AV block (ICD-10 - I44.2)</td><td/><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Ischemic cardiomyopathy (ICD-10 - I25.5)</td><td/><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>H/O mechanical aortic valve replacement (ICD-10 - Z95.2)</td><td>Mechanical Aortic valve. INR monitored per PCP office</td><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Severe obesity (BMI &gt;= 40) (ICD-10 - E66.01)</td><td/><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Other</td><td/><td>(MModal.) speech recognition transcription software was used to create portions of this document.  An attempt at proofreading has been made to minimize errors.  Please call if questions.</td><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Biventricular automatic implantable cardioverter defibrillator in situ</td><td>[REDACTED] has a longstanding history of paroxysmal atrial fibrillation with low burden of atrial tachyarrhythmia and on suppressive therapy with sotalol with acceptable QTC.  He also has a history of mechanical aortic valve on Coumadin, nonischemic cardiomyopathy with LVEF of 35% per TTE performed in [REDACTED] on guideline directed medical therapy.  As described above he has newly redeveloped atrial fibrillation although he has not had any significant symptoms.  He has reverted to atrially paced rhythm.  I would simply continue current management unless he develops more sustained and symptomatic atrial tachyarrhythmia in which case we could consider catheter ablation.  We will continue to follow his device remotely and see him in follow-up.</td></tr><tr><td ID="instructionpot2">Other</td><td>(MModal.) speech recognition transcription software was used to create portions of this document.  An attempt at proofreading has been made to minimize errors.  Please call if questions.</td></tr></tbody></table><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">ECG- COMPLETE (93000) IH</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 months with [REDACTED], Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 09:00:00 AM, [REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt2">Provider Name:[REDACTED], [REDACTED] 11:00:00 AM, [REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 8X400066973 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">PROGRESS NOTE</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>8X400066973</td><td align="right"><span class="bold">Provider: </span>[REDACTED], DNP</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>67 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td><td align="right"><span class="bold"> CHN#: </span>1174061808</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED]</td></tr>--&gt;    </tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   AFIB on remote</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Patient History</span>: <br/>       Mr. [REDACTED] is seen [REDACTED] in the [REDACTED] at [REDACTED] for follow-up. He is a [REDACTED] gentleman from [REDACTED] but since moved to [REDACTED].  He underwent mechanical aortic valve replacement with a St. Jude medical prosthesis in [REDACTED].  His other medical history is notable for  PAF, nonischemic cardiomyopathy with EF 40%, hypertension, mixed hyperlipidemia, asthma, and morbid obesity.  Mr. [REDACTED] was initially seen and 2008 when he presented to [REDACTED] with shocks due to a defibrillator lead fracture.  He suffered complete AV block subsequently and had initially a dual-chamber pacemaker placed.  His device was later upgraded to a dual-chamber defibrillator because of persistent left ventricular dysfunction with a Medtronic Sprint fidelis lead. The lead had been on recall watch due to fracture and indeed [REDACTED] presented with lead failureat the time. We extracted his ventricular leads and implanted a new Medtronic defibrillator lead in [REDACTED].  He has undergone and generator change out performed in [REDACTED].<br/><br/>The echocardiogram performed in the summer of 2015 demonstrates a left ventricular ejection fraction of 44% which was described as being significantly improved.  He had a repeat TTE by [REDACTED] in [REDACTED] which measure left ventricular ejection fraction similarly of 40 percent. [REDACTED] was was admitted to [REDACTED] on [REDACTED] with atypical chest pain and shortness of breath. He underwent coronary angiography by [REDACTED] that showed a normal functioning aortic prosthesis but no obstructive coronary disease. He is followed by my associate [REDACTED] who repeated transthoracic echocardiogram on [REDACTED] and the study showed LVEF of 35% with left ventricular diastolic parameters consistent with severe grade 3 diastolic dysfunction but also global hypokinesis with regional variation.  Saint Jude mechanical aortic prosthetic valve revealed no significant paravalvular leak or regurgitation as indicated below.  He had been maintained on guideline directed medical therapy.<br/><br/>   His St. Jude Medical quadra Assura CRT-D was remotely interrogated on [REDACTED] and showed well-functioning device. As such, he underwent successful generator change out.  Device has detected episodes of atrial fibrillation that began on [REDACTED] with mostly controlled ventricular response.  Overall atrial tachyarrhythmia burden was estimated at 4.1%.  He is atrially paced 77%, Bi V 98%.  Device is programmed DDDR 70-120 beats per minute with VT zone 150 beats per minute to monitor, VT zone to 176 beats per minute ATP x3 followed by 36 J, 40.0J and 40.0 Jx2, VF ATPx1, 36 J, 40.0J and 40.0 Jx4.  He has not received any device therapies.  Had been on Coumadin with good adherence to therapy and most recent INR measured 2.8.  He has not had any bleeding or bruising.  [REDACTED] I am seeing her for follow-up and he tells me that he feels well.  I informed him he had some episodes of atrial fibrillation as described above he tells me that he is completely unaware of the arrhythmia.  [REDACTED] informed me that he does have a history of COPD and asthma and lately he has been using bronchodilator more than usual.  I interrogated his [REDACTED] CRT D and shows well-functioning device.  He is atrially paced 72% Bi V paced 98%.  Pacing impedances and thresholds were stable.  He has not received any therapies. The CorVue is within normal limits.  Device battery is adequate at 61%.  It seems that his last episode of atrial tachyarrhythmia was this morning at 9:58 a.m. lasting approximately 3 hours and 8 minute and since then he has not had any further a atrial tachyarrhythmia.  He remains on sotalol and Coumadin with good adherence to therapy and denies any bleeding or bruising. The 12 lead EKG performed [REDACTED] shows AV sequential biventricular paced rhythm with manually calculated QTC of 480 milliseconds.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">CARDIOLOGY</span>: <br/>      Constitutional: Patient denies fever, chills, weight loss. Cardiovascular: See HPI for details. Eyes: Patient denies blurry vision, loss of vision, double vision, glaucoma. Ears, Nose, Mouth, Throat: Patient denies hearing loss, sore throat, sinus problems. Respiratory: Patient denies: cough, wheezing, hemoptysis. Gastrointestinal: Patient denies: , nausea, vomiting, dysphagia, heart burn, abdominal pain, ulcers, hiatal hernia, hematemasis, blood in stool, constipation, diarrhea. Genitourinary: Patient denies: hematuria, dysuria, difficulty urinating, kidney problems. Musculoskeletal: Patient denies:, myalgias, arthralgias, arthritis. Integumentary/Breast: Patient denies: rash, skin disorders.. Neurological: Patient denies:, headaches, seizures, dizziness/lightheadedness, memory loss, insomnia, gait abnormality. Psychiatric: Patient denies: anxiety, depression, sleep disturbance, drug abuse. Endocrine: Patient denies: fatigue, diabetes, thyroid disease..   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span>  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> St. Judes AVR 2005BiV ICD 2013ST.JUDE REPLACEMENT 03/2022</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> BAYFRONT- SOB 2022</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Mother: alive 73 yrs. Father: alive [REDACTED] yrs,  diagnosed with Diabetes. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   Alcohol Use <br/>      Patient <span class="italics">does not use alcohol</span><br/>   Tobacco Status <br/>      Patient is <span class="italics">a former smoker non tobacco user</span><br/>      Quit in: <span class="italics">2005</span><br/>   Exercise: yes, walking 2-3 times a week. <br/>   Marital Status: Legally Separated. <br/>   Lives with: alone. <br/>   Illicit Drug Use <br/>      Patient/Family reports: <span class="italics">Current illicit drug use CBD gummy</span><br/>   Caffeine: no. <br/>   Drugs: no. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingAspirin 81 MG Tablet Delayed Release 1 tablet Orally Once a day Calcium 500 MG Tablet 1 tablet with meals Orally Twice a day Carvedilol 12.5 MG Tablet 1 tablet Orally Twice a day Duloxetine HCl 60 MG Capsule Delayed Release Particles 1 capsule Orally Twice a day Entresto 24-26 MG Tablet 1 tablet Orally Twice a day Furosemide 40 MG Tablet 1 tablet Orally Once a day HydrOXYzine HCl 25 MG Tablet 1 tablet as needed Orally every 8 hrs Lyrica 50 MG Capsule 1 capsule Orally Three times a day Rosuvastatin Calcium 20 MG Tablet 1 tablet Orally Once a day Sotalol HCl 80 MG Tablet 1 tablet Orally every 12 hrs Vitamin D3 10 MCG (400 UNIT) Tablet 1 tablet Orally Once a day Warfarin Sodium 3 MG Tablet 1 tablet Orally Once a day Xanax 0.25 MG Tablet 1 tablet Orally As needed Zolpidem Tartrate 10 MG Tablet 1 tablet at bedtime as needed Orally Once a day Taking Aspirin 81 MG Tablet Delayed Release 1 tablet Orally Once a day Taking Calcium 500 MG Tablet 1 tablet with meals Orally Twice a day Taking Carvedilol 12.5 MG Tablet 1 tablet Orally Twice a day Taking Duloxetine HCl 60 MG Capsule Delayed Release Particles 1 capsule Orally Twice a day Taking Entresto 24-26 MG Tablet 1 tablet Orally Twice a day Taking Furosemide 40 MG Tablet 1 tablet Orally Once a day Taking HydrOXYzine HCl 25 MG Tablet 1 tablet as needed Orally every 8 hrs Taking Lyrica 50 MG Capsule 1 capsule Orally Three times a day Taking Rosuvastatin Calcium 20 MG Tablet 1 tablet Orally Once a day Taking Sotalol HCl 80 MG Tablet 1 tablet Orally every 12 hrs Taking Vitamin D3 10 MCG (400 UNIT) Tablet 1 tablet Orally Once a day Taking Warfarin Sodium 3 MG Tablet 1 tablet Orally Once a day Taking Xanax 0.25 MG Tablet 1 tablet Orally As needed Taking Zolpidem Tartrate 10 MG Tablet 1 tablet at bedtime as needed Orally Once a day DiscontinuedAllegra Allergy 180 MG Tablet 1 tablet as needed Orally Once a day Medication List reviewed and reconciled with the patientDiscontinued Allegra Allergy 180 MG Tablet 1 tablet as needed Orally Once a day Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 70 in, Ht-cm: 177.8 cm, Wt: 297 lbs, Wt-kg: 134.72 kg, BMI: <span class="bold">42.61</span>, Weight Change: 2 lbs, Body Surface Area: 2.58, BP: <span class="bold">132/90</span>, HR: <span class="bold">75</span>, Respiratory Rate: <span class="bold">16</span>, Oxygen sat %: <span class="bold">99</span>.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">CARDIOLOGY:</span><br/>      Constitutional: General appearance: no acute distress, well built and nourished. <br/>      Head and Face: normocephalic, atraumatic. <br/>      Eyes: Sclera: anicteric. Conjuctiva: pink. <br/>      Ears, Nose, Mouth, Throat: normocephalic, atraumatic. <br/>      Neck: no JVD, no carotid bruit. <br/>      Respiratory: normal respiratory effort, clear to auscultation bilaterally anteriorly and posteriorly without wheezes, crackles, or rhonchi. <br/>      Cardiovascular: normal rate, normal S1S2, regular rhythm, no murmurs. <br/>      Chest: Left pectoralis muscle device pocket site healed well.  Fully expanded, nontender to palpation. <br/>      Gastrointestinal/Abdomen: soft, non-tender/non-distended, bowel sounds normoactive. <br/>      Extremities: no clubbing, no cyanosis, no edema. <br/>      Skin: warm and dry. <br/>      Neurologic/Psychiatric: alert, cooperative, oriented x3, appropriate mood and affect, answers questions appropriately, alert .    <br/>   <span class="Underline"> Previous Cardiology Testing:</span><br/>      Echo:  TTE [REDACTED]:<br/>        <br/>        CONCLUSIONS:1. Moderately dilated left ventricle. Moderate eccentric hypertrophy. Moderately depressed left ventricular systolic function.LV Ejection Fraction, biplane Simpsons, is 35 %. LV Ejection Fraction, visually, is 30-35 %. Left ventricular diastolic parametersare consistent with severe (Grade III) diastolic dysfunction (restrictive physiology). The average global longitudinal strain rateis abnormal (&lt; -16%).2. There is severe global hypokinesis with regional variation.3. Echo density in right atrium suggestive of catheter, pacer lead, or ICD lead.4. A St Jude mechanical prosthetic valve is present in the aortic position. The valve shows mild to moderate thickening.Doppler parameters are consistent with normal functioning valve. No evidence of significant paravalvular leak nor valvularregurgitation. Doppler parameters and gradients are similar to those obtained in [REDACTED] without a significant interval change.5. No other significant valvular abnormalities.6. No pericardial effusion.7. There is mild aortic root dilation. The ascending aorta is mildly dilated at 4.1 cm.8. Of note: It should be mentioned that with depressed LV systolic function, assessment of aortic valve gradient could beunderestimated. However, there is no significant interval change compared to the last echo from 2016.9. Clinical correlation is recommended..    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Biventricular automatic implantable cardioverter defibrillator in situ - Z95.810 (Primary) 2. PAF (paroxysmal atrial fibrillation) - I48.0 3. VT (ventricular tachycardia) - I47.20 4. Complete AV block - I44.2 5. Ischemic cardiomyopathy - I25.5, Reported four cardiac catheterization without intervention in the past- nonischemic etiology 6. H/O mechanical aortic valve replacement - Z95.2, Mechanical Aortic valve. INR monitored per PCP office 7. Mixed hyperlipidemia - E78.2 8. Severe obesity (BMI &gt;= 40) - E66.01 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Biventricular automatic implantable cardioverter defibrillator in situ</span> <br/>Notes: [REDACTED] has a longstanding history of paroxysmal atrial fibrillation with low burden of atrial tachyarrhythmia and on suppressive therapy with sotalol with acceptable QTC.  He also has a history of mechanical aortic valve on Coumadin, nonischemic cardiomyopathy with LVEF of 35% per TTE performed in [REDACTED] on guideline directed medical therapy.  As described above he has newly redeveloped atrial fibrillation although he has not had any significant symptoms.  He has reverted to atrially paced rhythm.  I would simply continue current management unless he develops more sustained and symptomatic atrial tachyarrhythmia in which case we could consider catheter ablation.  We will continue to follow his device remotely and see him in follow-up.  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Others </span> <br/>Notes: (MModal.) speech recognition transcription software was used to create portions of this document.  An attempt at proofreading has been made to minimize errors.  Please call if questions.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">  Imaging:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>     <span class="Underline">Imaging: ECG- COMPLETE (93000) IH</span></td></tr><tr><td><ul><li/></ul></td></tr><tr><td/></tr><tr><td/></tr><tr><td/></tr><tr><td/></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 93000 EKG COMPLETE93284 PRGRMG EVAL IMPLANTABLE IN PERSON MULTI LEAD DFB, Modifiers: 26  93290 INTERROG DEV EVAL ICPMS IP, Modifiers: 26  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  Universal PAF (Patient Assessment Form): <br/>       Fall Risk Assessment <br/>          Date Screening Completed: <span class="italics">[REDACTED]</span><br/>          Increased Fall Risk factors: <span class="italics">History of falls [REDACTED], Difficulty ambulating (walks with cane or [REDACTED]), Environmental hazard (stairs/loose rug in home, etc.)</span><br/>          History Falls in Past Year: <span class="italics">Two or more falls without injury in past year</span><br/>          A positive response is considered at risk. Addressed: <span class="italics">Patient education</span><br/>       Ambulatory Status <br/>          Patient: <span class="italics">is independent, uses a cane</span><br/>  Quality Measures: <br/>       High Blood Pressure screening and follow up: <br/>          Intervention Order <span class="italics">Yes</span><br/>          Follow Up for BP reading with PCP/Alternative Provider <span class="italics">Follow-up 1 month (finding)  </span><br/>          Lifestyle Recommendation <span class="italics">Lifestyle education (procedure) [ lab test for hypertension or ECC ]</span><br/>          Patient's <span class="italics">Pre-hypertensive or Hypertensive blood pressure reading documented, indicated follow-up documented</span><br/>       Weight Assessment <br/>          Above Normal BMI Follow-Up <span class="italics">Lifestyle education regarding diet</span><br/>       Left Ventricular Ejection Fraction <br/>          Results (%) <span class="italics">35</span><br/>          Date  <span class="italics">[REDACTED]</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 months with [REDACTED]</td></tr></tbody></table></li></ul><ul><li/></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , DNP, ARNP9268608  on [REDACTED] 04:04 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], DNP</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 01:11 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="12">CARDIOLOGY</td><td>Constitutional:</td><td colspan="2">General appearance: no acute distress, well built and nourished</td></tr><tr><td>Head and Face:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Eyes:</td><td colspan="2">Sclera: anicteric. Conjuctiva: pink</td></tr><tr><td>Ears, Nose, Mouth, Throat:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Neck:</td><td colspan="2">no JVD, no carotid bruit</td></tr><tr><td>Respiratory:</td><td colspan="2">normal respiratory effort, clear to auscultation bilaterally anteriorly and posteriorly without wheezes, crackles, or rhonchi</td></tr><tr><td>Cardiovascular:</td><td colspan="2">normal rate, normal S1S2, regular rhythm, no murmurs</td></tr><tr><td>Chest:</td><td colspan="2">Left pectoralis muscle device pocket site healed well.  Fully expanded, nontender to palpation</td></tr><tr><td>Gastrointestinal/Abdomen:</td><td colspan="2">soft, non-tender/non-distended, bowel sounds normoactive</td></tr><tr><td>Extremities:</td><td colspan="2">no clubbing, no cyanosis, no edema</td></tr><tr><td>Skin:</td><td colspan="2">warm and dry</td></tr><tr><td>Neurologic/Psychiatric:</td><td colspan="2">alert, cooperative, oriented x3, appropriate mood and affect, answers questions appropriately, alert </td></tr><tr><td> Previous Cardiology Testing</td><td>Echo: </td><td colspan="2">TTE [REDACTED]:  CONCLUSIONS:1. Moderately dilated left ventricle. Moderate eccentric hypertrophy. Moderately depressed left ventricular systolic function.LV Ejection Fraction, biplane Simpsons, is 35 %. LV Ejection Fraction, visually, is 30-35 %. Left ventricular diastolic parametersare consistent with severe (Grade III) diastolic dysfunction (restrictive physiology). The average global longitudinal strain rateis abnormal (&lt; -16%).2. There is severe global hypokinesis with regional variation.3. Echo density in right atrium suggestive of catheter, pacer lead, or ICD lead.4. A St Jude mechanical prosthetic valve is present in the aortic position. The valve shows mild to moderate thickening.Doppler parameters are consistent with normal functioning valve. No evidence of significant paravalvular leak nor valvularregurgitation. Doppler parameters and gradients are similar to those obtained in [REDACTED] without a significant interval change.5. No other significant valvular abnormalities.6. No pericardial effusion.7. There is mild aortic root dilation. The ascending aorta is mildly dilated at 4.1 cm.8. Of note: It should be mentioned that with depressed LV systolic function, assessment of aortic valve gradient could beunderestimated. However, there is no significant interval change compared to the last echo from 2016.9. Clinical correlation is recommended.</td></tr></tbody></table><br/></li></ul></div><br/><br/>
</body></html>